{
  "id": "5c011057133db5eb78000025",
  "type": "factoid",
  "question": "In which phase of clinical trials was sutezolid in 2018?",
  "ideal_answer": "By 2018 sutezolid had been evaluated in phase II clinical trials.",
  "documents": [
    "http://www.ncbi.nlm.nih.gov/pubmed/25431273"
  ],
  "snippets": [
    {
      "text": "After decades of quiescence in the development of antituberculosis medications, bedaquiline and delamanid have been conditionally approved for the treatment of drug-resistant tuberculosis, while several other novel compounds (AZD5847, PA-824, SQ109 and sutezolid) have been evaluated in phase II clinical trials. ",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/25431273",
      "beginSection": "abstract",
      "endSection": "abstract"
    }
  ],
  "concepts": [],
  "exact_answer": "phase II"
}